The Rise and Fall of Novare Capital Management: A Q4 2022 vs. Q1 2023 Holdings Comparison

For investors, tracking changes in a fund's holdings is crucial for a successful portfolio. One company, Novare Capital Management LLC, recently announced their Q4 2022 vs. Q1 2023 holdings comparison. The comparison reveals a mixed bag of gains and losses across several industries. In this blog post, we will delve into the details of the report and analyze the notable changes in Novare Capital Management's holdings.

Introduction

Novare Capital Management LLC is an SEC registered investment advisory firm that specializes in wealth management, financial planning, and investment strategies. The company uses fundamental analysis, technical analysis, and quantitative analysis to select securities for its clients. With a keen focus on asset allocation and risk management, Novare Capital Management LLC helps clients achieve their financial goals. The company recently released its latest 13F holdings report, comparing Q4 2022 vs. Q1 2023.

Main Body

Novare Capital Management LLC's latest holdings comparison report revealed an overall decrease of -1.3% in the total value of the fund's holdings. Despite the decrease, the report highlighted several companies that saw significant gains and losses in their holdings between the two quarters.

One of the biggest holdings in Novare Capital Management LLC's portfolio is SPDR S&P 500 ETF TR (SPY). Between Q4 2022 and Q1 2023, the company decreased its holdings in SPY by -1.5%, from 108,236 to 106,647 shares. Despite the decrease in shares, the fund's value increased by 5.5%, from $41,392,000 to $43,660,000. The increase in the value of SPY's shares suggests that despite holding fewer shares, Novare Capital Management LLC has a solid position in the ETF.

One of the biggest losses in the portfolio was seen in Merck & Co Inc (MRK). Between Q4 2022 and Q1 2023, the company reduced its holdings by -11.2%, from 168,881 to 149,997 shares. The value of the shares also decreased by -14.8%, from $18,737,000 to $15,958,000. The decrease in shares and value suggests that Novare Capital Management LLC is moving away from Merck & Co Inc as a viable investment.

Another notable change in Novare Capital Management LLC's holdings was seen in the company's holdings of Tesla Inc (TSLA). The company increased its holdings in TSLA by 27.1%, from 21,562 to 27,385 shares. The value of the shares increased by 113.9%, from $2,655,000 to $5,681,000. The significant increase in shares and value suggests that Novare Capital Management LLC is bullish on Tesla's future performance.

Conclusion

The Q4 2022 vs. Q1 2023 holdings comparison report by Novare Capital Management LLC reveals an insightful analysis of the fund's holdings. While the overall value of the holdings decreased by -1.3%, the report shows that the company made several gains and losses across different industries. Novare Capital Management LLC shows a solid position in SPDR S&P 500 ETF TR (SPY), while moving away from Merck & Co Inc as a viable investment. The fund's bullish outlook on Tesla Inc (TSLA) suggests that the company is confident in TSLA's future performance. For investors, this report offers an opportunity for insight into one company's holdings and offers a glimpse into potential investment strategies.